Visão Geral
Variação de preço das ações
24h
Atual
Mín
1.18
Máximo
1.24
Recomendações | Comprar |
|---|---|
Previsão para 12 meses | +222.58% upside |
BioNano Genomics Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Notícias Relacionadas
3 de set. de 2026, 23:56 UTC
Missouri American Water acquired Neosho's water systems for $34.5 million, adding 5,400 customers. Shares of American Water Works traded higher in after-market hours.
Ler
3 de set. de 2026, 23:56 UTC
Paychex receives a buy rating on strong revenue growth and strategic AI integration. After-market trading has shown little change since Thursday's close.
Ler
3 de set. de 2026, 23:56 UTC
Jefferies initiated coverage on Nexgen Energy with a Buy rating and a C$21 price target. Shares moved higher in after-market hours.
Ler
3 de set. de 2026, 23:51 UTC
Regeneron Pharmaceuticals faces a class action lawsuit over misleading statements about its Phase III Fianlimab-Libtayo Study, with shares trading lower in after-market hours.
Ler
3 de set. de 2026, 23:51 UTC
Dutch Bros Inc filed a mixed securities shelf registration, enabling potential issuance of various securities. Shares are trading higher in after-market hours.
Ler
3 de set. de 2026, 23:51 UTC
Tesla Inc. shares are lower in after-market trading following the invite-only launch event for its Cybercab in Austin, as details remain restricted.
Ler
3 de set. de 2026, 23:46 UTC
Weyerhaeuser Co remains about 4.95% below its 20-day moving average. Shares were roughly flat in after-market hours following a price target cut to $28.
Ler
3 de set. de 2026, 23:46 UTC
Hewlett Packard Enterprise shares are lower in after-market trading, despite strong networking revenue guidance and broader market gains ahead of employment data.
Ler
3 de set. de 2026, 23:41 UTC
JP Morgan upgrades CPRT to Overweight, raises target to $40 after-market.
Ler
3 de set. de 2026, 23:41 UTC
Johnson & Johnson's shares are lower in after-market trading following FDA approval of IMAAVY and a jury verdict in a talc case.
Ler
3 de set. de 2026, 23:36 UTC
Ulta Beauty will participate in a Fireside Chat at the Barclays Global Consumer Conference on September 10, 2026. Shares are higher in after-market trading.
Ler
3 de set. de 2026, 23:31 UTC
Honeywell International Inc shares are lower in after-hours trading, despite broader market gains. The stock is near the lower end of its one-month range.
Ler
3 de set. de 2026, 23:26 UTC
Jefferies maintained a Buy rating on Five Below and raised its price target to $420. Shares are trading higher in after-market hours following the updates.
Ler
3 de set. de 2026, 23:21 UTC
Meta Platforms Inc. shares are higher in after-market hours, supported by a Buy rating from Bank of America with a price target of $810.
Ler
3 de set. de 2026, 23:21 UTC
Thermo Fisher Scientific shares are lower in after-market hours despite CLSA initiating coverage with an Outperform rating and a $748 price target.
Ler
3 de set. de 2026, 23:11 UTC
Ethereum is trading higher during Thursday's session, remaining above its 20-day moving average and near the upper end of its one-month range.
Ler
3 de set. de 2026, 23:11 UTC
Ethereum is trading higher today, remaining above its 20-day moving average and near the upper end of its one-month trading range.
Ler
3 de set. de 2026, 23:05 UTC
USD/HKD trades roughly flat amid stable market activity. An increase in USDE supply to $4.26 billion may influence dynamics but has not impacted prices today.
Ler
3 de set. de 2026, 23:05 UTC
WEX Inc. shares decline in after-market hours despite announcing an integration with Driivz Ltd. for electric vehicle charging solutions, with a fair value of $187.30.
Ler
3 de set. de 2026, 23:05 UTC
Elastic NV plans to integrate OpenAI GPT cyber models into its Elastic Security platform, enhancing security capabilities. Shares are trading roughly flat in after-market hours.
Ler
3 de set. de 2026, 23:05 UTC
The USD/PLN exchange rate is declining amid mixed U.S. jobless claims data, with initial claims rising slightly above expectations.
Ler
3 de set. de 2026, 23:02 UTC
Lululemon Athletica reported second-quarter revenue of $2.42 billion, below estimates. The stock fell sharply in after-market hours, reaching its lowest level since May 2018.
Ler
3 de set. de 2026, 23:02 UTC
DocuSign shares rise in after-market trading following strong fiscal Q2 results and raised revenue guidance, despite earlier pulling back from a session high.
Ler
3 de set. de 2026, 23:01 UTC
PulteGroup Inc shares are higher in after-market hours following a Buy rating from StoneX analyst Michael, who set a price target of $148.00.
Ler
3 de set. de 2026, 23:01 UTC
eGain Corp shares are lower in after-market trading following disappointing fiscal 2027 guidance, despite reporting revenue and adjusted EPS that exceeded estimates.
Ler
3 de set. de 2026, 23:01 UTC
Concrete Pumping Holdings reported strong Q3 results, raising revenue guidance and announcing a quarterly dividend, driving shares higher in after-market trading.
Ler
3 de set. de 2026, 23:01 UTC
UiPath Inc shares declined in after-market hours despite reporting second-quarter revenue of $410 million and raising its fiscal year 2027 outlook.
Ler
3 de set. de 2026, 23:01 UTC
Oxford Industries reports second-quarter sales of $394 million and lowers full-year adjusted EPS guidance to $1.60-$2.00, leading shares lower in after-market hours.
Ler
3 de set. de 2026, 23:01 UTC
Strategy Inc shares declined after hours, retracing from earlier gains amid social media discussions and news from Iran affecting sentiment.
Ler
3 de set. de 2026, 23:01 UTC
Smith & Wesson Brands reported strong Q1 results, with net sales of $112.6 million and adjusted EPS of $0.06, boosting shares in after-market trading.
Ler
Comparação entre Pares
Variação de preço
BioNano Genomics Inc Previsão
Preço-alvo
By TipRanks
Previsão para 12 meses
Média 4 USD 222.58%
Máximo 4 USD
Mínimo 4 USD
Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para BioNano Genomics Inc - Dist nos últimos 3 meses.
Consenso de Avaliação
By TipRanks
Comprar
1 ratings
1
Comprar
0
Manter
0
Vender
Com base em 1 analistas que deram avaliações de ações para BioNano Genomics Inc - Dist nos últimos 3 meses.
Informação Financeira
$